BI

Bioservo Technologies ABFNSE Bioservo Technologies Stock Report

Last reporting period 30 Sep, 2023

Updated —

Last price

Market cap $B

0

Micro

Exchange

FNSE - First North Sweden

BIOS.ST Stock Analysis

BI

Uncovered

Bioservo Technologies AB is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

8/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

28.437 B

Bioservo Technologies AB engages in the development, manufacture, and marketing of wearable non-invasive devices. The company is headquartered in Kista, Stockholm. The company went IPO on 2017-05-22. The company is engaged in developing, producing and selling muscle strengthening equipment based on the patented SEM Technology (Soft Extra Muscle Technology). The technology implies so called intention detection logic that activates the support if the wearer initiates movement with a natural and intuitive movement. This is achieved by sensors that detect the user’s action and strengthens this action by activating the motors. Its main product is a SEM Glove. The products are designed for people that have an impaired grip strength caused by injured nerves, weakening in the muscles or pain in the muscles/muscular attachments. The product is applicable in the healthcare and industry sectors.

View Section: Eyestock Rating